ATE298576T1 - Arzneizubereitungen - Google Patents

Arzneizubereitungen

Info

Publication number
ATE298576T1
ATE298576T1 AT99967310T AT99967310T ATE298576T1 AT E298576 T1 ATE298576 T1 AT E298576T1 AT 99967310 T AT99967310 T AT 99967310T AT 99967310 T AT99967310 T AT 99967310T AT E298576 T1 ATE298576 T1 AT E298576T1
Authority
AT
Austria
Prior art keywords
medicinal preparations
medicinal
preparations
Prior art date
Application number
AT99967310T
Other languages
English (en)
Inventor
Terrence C Dahl
Lung-Chi J Yuan
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/211,613 external-priority patent/US6635278B1/en
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Application granted granted Critical
Publication of ATE298576T1 publication Critical patent/ATE298576T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
AT99967310T 1998-12-15 1999-12-14 Arzneizubereitungen ATE298576T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11240398P 1998-12-15 1998-12-15
US09/211,613 US6635278B1 (en) 1998-12-15 1998-12-15 Pharmaceutical formulations
PCT/US1999/029626 WO2000035460A2 (en) 1998-12-15 1999-12-14 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ATE298576T1 true ATE298576T1 (de) 2005-07-15

Family

ID=26809911

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99967310T ATE298576T1 (de) 1998-12-15 1999-12-14 Arzneizubereitungen

Country Status (19)

Country Link
EP (1) EP1140114B1 (de)
JP (1) JP4750946B2 (de)
KR (1) KR100624214B1 (de)
CN (2) CN100361664C (de)
AR (1) AR021670A1 (de)
AT (1) ATE298576T1 (de)
AU (1) AU759869B2 (de)
BR (1) BRPI9916820B8 (de)
CA (1) CA2355239C (de)
CO (1) CO5261557A1 (de)
DE (1) DE69926012T2 (de)
ES (1) ES2245130T3 (de)
HK (1) HK1040488A1 (de)
ID (1) ID30032A (de)
MY (1) MY126526A (de)
NZ (1) NZ511855A (de)
TR (1) TR200101746T2 (de)
TW (1) TWI230618B (de)
WO (1) WO2000035460A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2536972T5 (es) * 2000-07-21 2022-04-06 Gilead Sciences Inc Profármacos de análogos de nucleótidos de fosfonato y métodos para seleccionar y preparar los mismos
KR20040028947A (ko) * 2001-07-31 2004-04-03 하. 룬트벡 아크티에 셀스카브 에시탈로프람 함유 결정 조성물
AU2003284800A1 (en) 2002-11-12 2004-06-03 Tianjin Kinsly Pharmaceutical Co., Ltd. A new crystal form of adefovir dipivoxil and its composition
EP1635847B1 (de) 2003-06-13 2019-07-31 IDH Holding ApS Behandlung von symptomen im zusammenhang mit bakterieller vaginose
ITMI20071594A1 (it) 2007-08-02 2009-02-03 Solmag Spa Forma cristallina monoidrata di adefovir dipivoxil
KR20100031045A (ko) * 2008-09-11 2010-03-19 씨제이제일제당 (주) 아데포비어 디피복실의 정제방법
CN104173356A (zh) * 2008-09-17 2014-12-03 Cj第一制糖株式会社 肝适能固态分散物、包括其的药的组成物以及其制备方法
KR101089620B1 (ko) * 2009-07-20 2011-12-06 경희대학교 산학협력단 무수결정형 아데포비어 디피복실 및 이온성 액체를 사용한 이의 제조 방법
EP2343056A1 (de) 2009-12-30 2011-07-13 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Herstellung einer stabilen festen Dispersion von amorphem Adefovir dipivoxil
AU2015384801B2 (en) 2015-03-04 2022-01-06 Eisai R&D Management Co., Ltd. Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer
CN108883091A (zh) * 2015-12-22 2018-11-23 X4 制药有限公司 用于治疗免疫缺陷病的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58201726A (ja) * 1982-05-18 1983-11-24 Meiji Seika Kaisha Ltd 安定な製剤の製造法
CS263952B1 (en) * 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
US4704365A (en) * 1986-02-24 1987-11-03 Abbott Laboratories Composition and method for stabilization of dinucleotides
CA2035841C (en) * 1990-02-22 1996-02-13 Harry B. Demopoulos Storage-stable glucosamine sulphate oral dosage forms and methods for their manufacture
ATE167679T1 (de) * 1990-09-14 1998-07-15 Acad Of Science Czech Republic Wirkstoffvorläufer von phosphonaten
JPH0825905B2 (ja) * 1990-11-20 1996-03-13 武田薬品工業株式会社 医薬固形組成物用安定化剤および安定化方法
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
ATE178794T1 (de) * 1993-01-19 1999-04-15 Warner Lambert Co Stabilisierte, oral anzuwendende zusammensetzung enthaltend die verbindung ci-981 und verfahren
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
JP2974550B2 (ja) * 1993-06-01 1999-11-10 ビオフェルミン製薬株式会社 経口投与用固体組成物
US5919776A (en) * 1996-12-20 1999-07-06 Merck & Co., Inc. Substituted aminoquinolines as modulators of chemokine receptor activity
JP2762998B2 (ja) * 1997-04-25 1998-06-11 武田薬品工業株式会社 医薬固形組成物用安定化剤および安定化方法
JPH114666A (ja) * 1997-06-17 1999-01-12 Otsuka Pharmaceut Co Ltd マグネシウム補給発泡剤組成物
CA2596320C (en) * 1997-07-25 2008-12-23 Gilead Sciences, Inc. Nucleotide analog compositions

Also Published As

Publication number Publication date
ID30032A (id) 2001-11-01
HK1040488A1 (en) 2002-06-14
CN1202829C (zh) 2005-05-25
BRPI9916820B8 (pt) 2023-04-25
TWI230618B (en) 2005-04-11
CA2355239A1 (en) 2000-06-22
AR021670A1 (es) 2002-07-31
CO5261557A1 (es) 2003-03-31
JP4750946B2 (ja) 2011-08-17
BRPI9916820A2 (pt) 2001-10-30
CN1682743A (zh) 2005-10-19
CN1330547A (zh) 2002-01-09
BRPI9916820B1 (pt) 2018-04-03
WO2000035460A2 (en) 2000-06-22
TR200101746T2 (tr) 2001-12-21
KR100624214B1 (ko) 2006-09-18
CN100361664C (zh) 2008-01-16
DE69926012D1 (de) 2005-08-04
EP1140114A2 (de) 2001-10-10
NZ511855A (en) 2003-07-25
EP1140114B1 (de) 2005-06-29
CA2355239C (en) 2008-03-18
DE69926012T2 (de) 2006-05-04
WO2000035460A3 (en) 2000-11-09
ES2245130T3 (es) 2005-12-16
JP2002532429A (ja) 2002-10-02
AU2361300A (en) 2000-07-03
AU759869B2 (en) 2003-05-01
KR20010080765A (ko) 2001-08-22
MY126526A (en) 2006-10-31

Similar Documents

Publication Publication Date Title
IS5953A (is) Lyfjablöndur úr örgerðum eplerenonum
DK0921796T3 (da) Tetrahydrolipstatinholdige præparater
NO992339L (no) Farmasöytiske formuleringer
IS6040A (is) Valdekoxib efnablöndur
IS5425A (is) Læknislyf
NO20005913D0 (no) Legemiddelsammensetning
NO20012915L (no) Ny farmasöytisk formulering
NO20003967L (no) Farmasöytiske preparater
EE200200038A (et) Konservitud farmatseutilised preparaadid
ATE266383T1 (de) Dermatologische zubereitungen
DK1466615T3 (da) Farmaceutisk præparat
NO980546D0 (no) Farmasöytiske midler
ATE332132T1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
DE59707298D1 (de) Desodorierende zubereitungen
ID16781A (id) Formulasi-formulasi farmasi
ATE298576T1 (de) Arzneizubereitungen
NO994619D0 (no) Farmasöytiske blandinger
ITMI941169A0 (it) Formulazioni farmaceutiche
ATE246494T1 (de) Brausezubereitungen
NO20003141D0 (no) Farmasøytiske blandinger
ATE237309T1 (de) Arzneizubereitungen
EP1142589A4 (de) Medizinische zusammensetzungen
FI951155A0 (fi) Farmaseuttinen valmiste
DE50009295D1 (de) Vernetzerfreie zubereitungen
DE29618094U1 (de) Pharmazeutisches Präparat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties